Biotherapeutics are famously difficult to model, with many variables such as time and cost to account for and manage.

With a focus on in-silico methods to decrease the drug's time to marketability, Actimo Labs aims to bring AI-driven solutions to accelerate this pipeline.

Our vision is simple: we believe that life-changing drugs don't need to spend all that time in the development pipeline with a constant risk of failure. You worry about the impact, let us take care of the rest.